Clinical Trial Update: CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial at Vanderbilt is evaluating coenzyme Q10 with exercise for mitochondrial dysfunction in end-stage renal disease and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: End Stage Renal Disease | Phase 3 | Status: RECRUITING